Time-restricted eating can improve some cardiometabolic outcomes in specific settings, but it does not automatically outperform other eating schedules.

This page isolates one claim from the wider argument of The Human OS Manual.

The classification describes the evidence supporting this claim, not the Human OS framework as a whole.

Sutton et al. reported improvements in insulin sensitivity, blood pressure, and oxidative stress in a tightly controlled early time-restricted-feeding crossover study in men with prediabetes. Lowe et al. found no significant weight-loss advantage or broad metabolic benefit for a 16:8 schedule compared with a consistent-meal-timing control in adults with overweight or obesity.

These trials do not establish that time-restricted eating is universally beneficial, ineffective, superior, or harmful. They studied different populations, timing windows, controls, and endpoints.

The two sources are intentionally paired as support and counterbalance so the Evidence Map preserves heterogeneity rather than selecting one result as the rule.

Supported by appropriate human studies, major reviews, trials, cohort research, or converging evidence. The strength of the category does not remove population, dose, timing, or context limitations.

Sources are listed according to the role they play in this claim. One source may provide direct support, another may explain a mechanism, establish a limitation, or prevent an interpretation from becoming broader than the evidence allows.

The printed book preserves the claim inside the argument that gives it meaning. These references connect the current digital record to the first-edition evidence trail.

This claim connects to the following parts of the Human OS architecture. The module labels locate the claim inside the framework; they do not imply that the research source validates the architecture itself.